CAR T-Cell Therapy: Is CD28-CAR Heterodimerization Its Achilles’ Heel?
Guardado en:
Autores principales: | Leonardo M. R. Ferreira, Yannick D. Muller |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/90c7b03593cf43948e37aab8ab55cd77 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A novel CD34-derived hinge for rapid and efficient detection and enrichment of CAR T cells
por: Arthur Bister, et al.
Publicado: (2021) -
Quantification of cell-free DNAfor the analysis of CD19-CAR-T cells during lymphoma treatment
por: Thomas Mika, et al.
Publicado: (2021) -
Cell Therapy for Colorectal Cancer: The Promise of Chimeric Antigen Receptor (CAR)-T Cells
por: Cristina Aparicio, et al.
Publicado: (2021) -
Engineered CAR-Macrophages as Adoptive Immunotherapies for Solid Tumors
por: Christopher Sloas, et al.
Publicado: (2021) -
How Can We Engineer CAR T Cells to Overcome Resistance?
por: Glover M, et al.
Publicado: (2021)